Luis A. Balart

Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

Gary L. Davis, Luis A. Balart, Eugene R. Schiff et al. · New England Journal of Medicine · 1989 · 1.7K citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

E. Jenny Heathcote, Mitchell L. Shiffman, W. Graham E. Cooksley et al. · New England Journal of Medicine · 2000 · 886 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B

Jay H. Lefkowitch, Eugene R. Schiff, G. Davis et al. · Gastroenterology · 1993 · 374 citations

Medicine, Internal Medicine, Pathology +11

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao et al. · Gastroenterology · 2019 · 344 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17